Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy

被引：0
|
作者：
Fouzia Guestini
Katsuhiko Ono
Minoru Miyashita
Takanori Ishida
Noriaki Ohuchi
Saki Nakagawa
Hisashi Hirakawa
Kentaro Tamaki
Yasuyo Ohi
Yoshiaki Rai
Yasuaki Sagara
Hironobu Sasano
Keely May McNamara
机构：
[1] Tohoku University,
[2] Tohoku Kousai Hospital,undefined
[3] Nahanishi Clinic,undefined
[4] Sagara Hospital,undefined
来源：
Breast Cancer Research and Treatment | 2019年 / 173卷
关键词：
Triple-negative breast cancer; Neoadjuvant chemotherapy; Mechanistic markers; Drug resistance; Residual disease; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：275 / 288
页数：13
相关论文
共 50 条
  • [21] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    BMC CANCER, 2011, 11
  • [22] Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy
    Vernaci, Grazia
    Savarino, Edoardo Vincenzo
    Patuzzi, Ilaria
    Facchin, Sonia
    Zingone, Fabiana
    Massa, Davide
    Faggioni, Giovanni
    Giarratano, Tommaso
    Miglietta, Federica
    Griguolo, Gaia
    Fassan, Matteo
    Lo Mele, Marcello
    Gasparini, Elisa
    Bisagni, Giancarlo
    Guarneri, Valentina
    Dieci, Maria Vittoria
    ONCOLOGIST, 2023, 28 (09): : E703 - E711
  • [23] Predictors of Survival in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiotherapy
    Shao, S.
    Shi, W.
    Zhang, L.
    Meng, J.
    Guo, X. M.
    Yu, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E333 - E333
  • [24] PostTreatment High Ki67 Expression Level (>10%) Is Significantly Associated with Distant Metastasis in Triple-Negative Breast Carcinomas Treated with Neoadjuvant Chemotherapy Followed by Surgery
    Duan, L.
    Yan, J.
    Sarode, V.
    Rao, R.
    Leitch, A. M.
    Euhus, D.
    Cao, D.
    Xie, X-J
    Peng, Y.
    MODERN PATHOLOGY, 2011, 24 : 37A - 37A
  • [25] PostTreatment High Ki67 Expression Level (>10%) Is Significantly Associated with Distant Metastasis in Triple-Negative Breast Carcinomas Treated with Neoadjuvant Chemotherapy Followed by Surgery
    Duan, L.
    Yan, J.
    Sarode, V.
    Rao, R.
    Leitch, A. M.
    Euhus, D.
    Cao, D.
    Xie, X-J
    Peng, Y.
    LABORATORY INVESTIGATION, 2011, 91 : 37A - 37A
  • [26] Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
    Hao, Qian
    Dai, Luyao
    Chang, Lidan
    Song, Dingli
    Liu, Dandan
    Ma, Xiaobin
    Wu, Hao
    Kang, Huafeng
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Ki67 can be used as a predictive factor for the effectiveness of neoadjuvant chemotherapy in breast cancer patients
    Kozar, Nejc
    Lovrec, Vida Gavric
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (06) : 150 - 156
  • [28] Patterns of survival and efficacy of chemotherapy in elderly patients with triple-negative breast cancer treated in the neoadjuvant setting
    Gordeeva, Olga
    Kolyadina, Irina
    Zhukova, Lyudmila
    Ganshina, Inna
    Komov, Dmitry
    Meshcheryakov, Andrey
    CANCER RESEARCH, 2020, 80 (04)
  • [29] Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy
    Ortolan, E.
    Appierto, V
    Silvestri, M.
    Miceli, R.
    Veneroni, S.
    Folli, S.
    Pruneri, G.
    Vingiani, A.
    Belfiore, A.
    Cappelletti, V
    Vismara, M.
    Dell'Angelo, F.
    De Cecco, L.
    Bianchi, G., V
    de Braud, F. G.
    Daidone, M. G.
    Di Cosimo, S.
    ESMO OPEN, 2021, 6 (02)
  • [30] Treatment outcomes in triple negative breast cancer patients undergoing neoadjuvant chemotherapy. The importance of Ki-67
    Rapoport, Bernardo Leon
    Barnard-Tidy, Jacqui
    van Eeden, Ronwyn
    Smit, Teresa
    Nayler, Simon
    Benn, Carol
    CANCER RESEARCH, 2020, 80 (04)
12345